Hummers, Laura K <br/><br/>
A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon.  [electronic resource] 

 -  Annals of the rheumatic diseases  Dec 2013 
 - 1962-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2012-201536  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Aged<br/>Chemistry, Pharmaceutical<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Gels<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Nitroglycerin--administration & dosage<br/>Raynaud Disease--drug therapy<br/>Regional Blood Flow--drug effects<br/>Skin--blood supply<br/>Skin Temperature--drug effects<br/>Treatment Outcome<br/>Vasodilator Agents--administration & dosage<br/>Young Adult